Neuronetics Files 8-K: Agreements, Acquisitions, Officer Changes
Ticker: STIM · Form: 8-K · Filed: Dec 10, 2024 · CIK: 1227636
| Field | Detail |
|---|---|
| Company | Neuronetics, Inc. (STIM) |
| Form Type | 8-K |
| Filed Date | Dec 10, 2024 |
| Risk Level | medium |
| Pages | 9 |
| Reading Time | 11 min |
| Key Dollar Amounts | $0.01, $10,000,000, $0.0846, $40 billion |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, acquisition, officer-changes, corporate-governance
TL;DR
Neuronetics 8-K: Big moves with deals, asset changes, and exec reshuffling.
AI Summary
On December 10, 2024, Neuronetics, Inc. filed an 8-K report detailing several significant events. These include the entry into a material definitive agreement, the completion of an acquisition or disposition of assets, and unregistered sales of equity securities. The report also notes the departure of directors or certain officers, the election of directors, the appointment of certain officers, and changes related to compensatory arrangements. Additionally, amendments to articles of incorporation or bylaws and a change in fiscal year were reported, alongside other events and financial statements.
Why It Matters
This 8-K filing indicates substantial corporate activity for Neuronetics, Inc., including potential strategic shifts through acquisitions or asset disposals and changes in its leadership structure.
Risk Assessment
Risk Level: medium — The filing covers multiple significant corporate actions including acquisitions, asset disposals, and changes in officers/directors, which can introduce uncertainty and risk.
Key Players & Entities
- Neuronetics, Inc. (company) — Registrant
- December 10, 2024 (date) — Date of Report
FAQ
What was the nature of the material definitive agreement entered into by Neuronetics, Inc. on December 10, 2024?
The filing indicates the entry into a material definitive agreement, but the specific details of this agreement are not provided in the summary information.
What type of acquisition or disposition of assets was completed by Neuronetics, Inc.?
The filing confirms the completion of an acquisition or disposition of assets, but the specifics of the transaction are not detailed in the provided text.
Were there any unregistered sales of equity securities by Neuronetics, Inc.?
Yes, the 8-K filing explicitly mentions unregistered sales of equity securities as one of the reported events.
What changes occurred regarding the directors and officers of Neuronetics, Inc.?
The filing reports the departure of directors or certain officers, the election of directors, and the appointment of certain officers, as well as changes to compensatory arrangements.
Did Neuronetics, Inc. amend its articles of incorporation or bylaws, or change its fiscal year?
Yes, the 8-K filing indicates that there were amendments to articles of incorporation or bylaws and a change in fiscal year.
Filing Stats: 2,707 words · 11 min read · ~9 pages · Grade level 12.2 · Accepted 2024-12-10 16:45:53
Key Financial Figures
- $0.01 — nge on which registered Common Stock ($0.01 par value) STIM The Nasdaq Global M
- $10,000,000 — Tranche 3 Loan in a principal amount of $10,000,000 and use the proceeds to finance, in par
- $0.0846 — Market Price") is less than or equal to $0.0846 (the "Minimum Price"), a cash payment
- $40 billion — sidential development projects and over $40 billion worth of estimated completion value. Mr
Filing Documents
- d897369d8k.htm (8-K) — 48KB
- d897369dex31.htm (EX-3.1) — 5KB
- d897369dex102.htm (EX-10.2) — 62KB
- d897369dex991.htm (EX-99.1) — 17KB
- 0001193125-24-274383.txt ( ) — 283KB
- stim-20241210.xsd (EX-101.SCH) — 3KB
- stim-20241210_lab.xml (EX-101.LAB) — 18KB
- stim-20241210_pre.xml (EX-101.PRE) — 11KB
- d897369d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (a) Financial Statements of Businesses or Funds Acquired The Company will file the financial statements required by this item in connection with the Arrangement by amendment to this Current Report on Form 8-K to be filed no later than 71 calendar days after the date on which this Current Report on Form 8-K is due. (b) Pro Forma Financial Information The Company will file the pro forma financial information required by this item in connection with the Arrangement by amendment to this Current Report on Form 8-K to be filed no later than 71 calendar days after the date on which this Current Report on Form 8-K is due. (d) Exhibits Exhibit Number Description 2.1* Arrangement Agreement by and between Neuronetics and Greenbrook dated August 11, 2024 (incorporated by reference to Exhibit 2.1 of the Company's Current Report on Form 8-K, filed with the SEC on August 13, 2024) 3.1 Certificate of Amendment of Ninth Amended and Restated Certificate of Incorporation 10.1 Form of Indemnification Agreement between the Registrant and its non-employee directors and officers (incorporated by reference to Exhibit 10.3 of the Company's Annual Report on Form 10-K filed with the SEC on March 8, 2024). 10.2 Consent and Amendment No. 1 to Credit Agreement and Guaranty and Warrant Certificate dated December 9, 2024 99.1 Press Release dated December 10, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) * Exhibits and/or schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The registrant hereby undertakes to furnish supplementally copies of any of the omitted exhibits and schedules upon request by the SEC; provided, however, that the registrant may request confidential treatment pursuant to Rule 24b-2 under the Exchange Act for any exhibits or schedules so furnished. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant